PAM
HRTX icon

Private Asset Management’s Heron Therapeutics HRTX Stock Holding History

Private Asset Management’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-77,841
Closed -$711K – 148
2021
Q4 		$711K Sell
77,841
-59,014
-43% -$603K 0.09% 96
2021
Q3 		$1.46M Sell
136,855
-40,503
-23% -$493K 0.2% 72
2021
Q2 		$2.75M Sell
177,358
-15,495
-8% -$247K 0.37% 52
2021
Q1 		$3.13M Buy
192,853
+22,339
+13% +$398K 0.44% 50
2020
Q4 		$3.61M Sell
170,514
-510
-0.3% -$8.86K 0.54% 45
2020
Q3 		$2.54M Buy
171,024
+24,345
+17% +$380K 0.42% 49
2020
Q2 		$2.16M Buy
146,679
+15,789
+12% +$259K 0.38% 53
2020
Q1 		$1.54M Buy
130,890
+15,420
+13% +$290K 0.32% 59
2019
Q4 		$2.71M Buy
115,470
+14,870
+15% +$329K 0.44% 56
2019
Q3 		$1.86M Buy
100,600
+4,650
+5% +$85.6K 0.32% 64
2019
Q2 		$1.78M Buy
95,950
+3,495
+4% +$69.8K 0.3% 64
2019
Q1 		$2.26M Sell
92,455
-1,427
-2% -$37.4K 0.4% 59
2018
Q4 		$2.44M Buy
93,882
+2,625
+3% +$72.2K 0.47% 56
2018
Q3 		$2.89M Sell
91,257
-2,493
-3% -$92.9K 0.45% 59
2018
Q2 		$3.64M Sell
93,750
-1,350
-1% -$43K 0.59% 53
2018
Q1 		$2.63M Buy
95,100
+8,125
+9% +$184K 0.45% 54
2017
Q4 		$1.57M Buy
86,975
+57,050
+191% +$930K 0.25% 69
2017
Q3 		$483K Buy
+29,925
New +$469K 0.08% 101

Other funds holding HRTX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Private Asset Management's HRTX Position: Q1 2022 in Review

Private Asset Management sold out of Heron Therapeutics (HRTX) in Q1 2022, closing a stake of 77,841 shares — an estimated $711K sold.

Private Asset Management first reported a position in HRTX in Q3 2017 and held it in 18 quarters. The position peaked at $3.64M in Q2 2018. 186 funds tracked by Wall St. Rank hold HRTX as of Q1 2022.

  • Private Asset Management reported no remaining Heron Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Private Asset Management sold 77,841 Heron Therapeutics shares in Q1 2022, an estimated $711K.
  • Private Asset Management first reported a position in Heron Therapeutics in Q3 2017 and held it in 18 quarters.
  • Private Asset Management's Heron Therapeutics position peaked at $3.64M in Q2 2018.
  • 186 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2022.

Based on Private Asset Management's 13F filing for Q1 2022, filed 4 Apr 2022.